STAAR Surgical Future Growth
Future criteria checks 4/6
STAAR Surgical is forecast to grow earnings and revenue by 33.7% and 13.5% per annum respectively. EPS is expected to grow by 31% per annum. Return on equity is forecast to be 7.9% in 3 years.
Key information
33.7%
Earnings growth rate
31.0%
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | 13.5% |
| Future return on equity | 7.9% |
| Analyst coverage | Good |
| Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 445 | 38 | 31 | 55 | 12 |
| 12/31/2025 | 386 | 18 | 19 | 39 | 14 |
| 12/31/2024 | 343 | 6 | 7 | 31 | 14 |
| 9/27/2024 | 341 | 22 | 26 | 47 | N/A |
| 6/28/2024 | 333 | 17 | 14 | 37 | N/A |
| 3/29/2024 | 326 | 15 | 21 | 41 | N/A |
| 12/29/2023 | 322 | 21 | -4 | 15 | N/A |
| 9/29/2023 | 310 | 20 | -34 | -14 | N/A |
| 6/30/2023 | 306 | 26 | -1 | 16 | N/A |
| 3/31/2023 | 295 | 33 | 17 | 35 | N/A |
| 12/30/2022 | 284 | 40 | 18 | 36 | N/A |
| 9/30/2022 | 279 | 38 | 22 | 41 | N/A |
| 7/1/2022 | 262 | 34 | 24 | 39 | N/A |
| 4/1/2022 | 243 | 29 | 19 | 33 | N/A |
| 12/31/2021 | 230 | 28 | 30 | 44 | N/A |
| 10/1/2021 | 217 | 23 | 44 | 55 | N/A |
| 7/2/2021 | 206 | 21 | 32 | 42 | N/A |
| 4/2/2021 | 179 | 11 | 28 | 36 | N/A |
| 1/1/2021 | 163 | 6 | 13 | 21 | N/A |
| 10/2/2020 | 156 | 9 | 2 | 11 | N/A |
| 7/3/2020 | 148 | 7 | 4 | 13 | N/A |
| 4/3/2020 | 153 | 13 | 7 | 17 | N/A |
| 1/3/2020 | 150 | 14 | 16 | 26 | N/A |
| 9/27/2019 | 142 | 9 | 11 | 18 | N/A |
| 6/28/2019 | 135 | 8 | 9 | 15 | N/A |
| 3/29/2019 | 129 | 6 | 7 | 11 | N/A |
| 12/28/2018 | 124 | 5 | 11 | 13 | N/A |
| 9/28/2018 | 118 | 4 | 10 | 12 | N/A |
| 6/29/2018 | 109 | 3 | N/A | 7 | N/A |
| 3/30/2018 | 97 | 1 | N/A | 6 | N/A |
| 12/29/2017 | 91 | -2 | N/A | 3 | N/A |
| 9/29/2017 | 88 | -2 | N/A | 2 | N/A |
| 6/30/2017 | 84 | -5 | N/A | 0 | N/A |
| 3/31/2017 | 84 | -6 | N/A | 3 | N/A |
| 12/30/2016 | 82 | -12 | N/A | 1 | N/A |
| 9/30/2016 | 81 | -13 | N/A | -1 | N/A |
| 7/1/2016 | 80 | -13 | N/A | -1 | N/A |
| 4/1/2016 | 78 | -12 | N/A | -3 | N/A |
| 1/1/2016 | 77 | -7 | N/A | -2 | N/A |
| 10/2/2015 | 73 | -8 | N/A | -4 | N/A |
| 7/3/2015 | 72 | -9 | N/A | -5 | N/A |
| 4/3/2015 | 74 | -9 | N/A | -8 | N/A |
| 1/2/2015 | 75 | -8 | N/A | -8 | N/A |
| 10/3/2014 | 77 | -7 | N/A | -5 | N/A |
| 7/4/2014 | 76 | -3 | N/A | -1 | N/A |
| 4/4/2014 | 74 | -1 | N/A | 1 | N/A |
| 1/3/2014 | 72 | 0 | N/A | 3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SR3's forecast earnings growth (33.7% per year) is above the savings rate (1%).
Earnings vs Market: SR3's earnings (33.7% per year) are forecast to grow faster than the German market (21.1% per year).
High Growth Earnings: SR3's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SR3's revenue (13.5% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: SR3's revenue (13.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SR3's Return on Equity is forecast to be low in 3 years time (7.9%).